Relationships among symptoms of gastroparesis to those of avoidant/restrictive food intake disorder in patients with gastroparesis

Author:

Hollis Erin1,Murray Helen Burton2,Parkman Henry P.3ORCID

Affiliation:

1. Lankenau Medical Center Philadelphia Pennsylvania USA

2. Department of Psychiatry, Eating Disorders Clinical Research Program Massachusetts General Hospital Boston Massachusetts USA

3. Gastroenterology Division Temple University Hospital Philadelphia Pennsylvania USA

Abstract

AbstractBackgroundPatients with symptoms of gastroparesis (Gp) often reduce food intake in attempt to manage their symptoms. Up to 40% of adults with Gp have been reported to have symptoms of a non‐body image‐based eating disorder, avoidant/restrictive food intake disorder (ARFID). However, whether ARFID symptoms precede or follow the diagnosis of Gp is unknown.MethodsFrom January 2021 to January 2022, consecutive adult patients with Gp at an academic center completed self‐report surveys for Gp symptom severity (patient assessment of upper gastrointestinal symptoms; PAGI‐SYM) and for ARFID (nine‐item ARFID screen; NIAS).Key ResultsOne hundred and seven patients (age 45.4 ± 17.2 yrs, 84.1% female, BMI 26.4 ± 7.3) with Gp (4‐h gastric retention 33.5 ± 21.8%) were included. Eighty‐two of the 107 Gp patients (77%) screened positive for ARFID. Positive ARFID screen was most often on the NIAS appetite subscale (84%) and fear subscale (76%), with a lower positive screen rate on the picky subscale (45%). Of the Gp who screened positive for ARFID, 38% reported that eating difficulties came after their Gp diagnosis, whereas 17% reported that eating difficulties preceded their Gp diagnosis, and 15% reported that both began at the same time.ConclusionsMany (77%) patients with Gp screened positive for ARFID. In Gp patients with ARFID, the Gp diagnosis was more likely to precede the development of eating difficulties. Thus, a subset of patients with Gp may be at risk for developing ARFID. Further longitudinal research is needed to confirm findings and identify risk factors.

Publisher

Wiley

Subject

Gastroenterology,Endocrine and Autonomic Systems,Physiology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3